{"organizations": [], "uuid": "0de20df298c597a25f3f742bbdb6f4bcb11a8a94", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-medicines-co-says-board-appointed/brief-medicines-co-says-board-appointed-christopher-visioli-as-cfo-idUSFWN1R90VC", "country": "US", "domain_rank": 408, "title": "BRIEF-Medicines Co Says Board Appointed Christopher Visioli As CFO", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-28T00:34:00.000+03:00", "replies_count": 0, "uuid": "0de20df298c597a25f3f742bbdb6f4bcb11a8a94"}, "author": "", "url": "https://www.reuters.com/article/brief-medicines-co-says-board-appointed/brief-medicines-co-says-board-appointed-christopher-visioli-as-cfo-idUSFWN1R90VC", "ord_in_thread": 0, "title": "BRIEF-Medicines Co Says Board Appointed Christopher Visioli As CFO", "locations": [], "entities": {"persons": [{"name": "christopher visioli", "sentiment": "negative"}, {"name": "christophe", "sentiment": "negative"}, {"name": "william o'connor", "sentiment": "none"}, {"name": "visioli", "sentiment": "none"}], "locations": [], "organizations": [{"name": "brief-medicines co says board", "sentiment": "negative"}, {"name": "sec", "sentiment": "none"}, {"name": "visioli as cfo reuters", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 27 (Reuters) - Medicines Co:\n* MEDICINES - ON MARCH 21, BOARD APPOINTED CHRISTOPHER VISIOLI CFO AND TREASURER OF COMPANY, EFFECTIVE IMMEDIATELY\n* MEDICINES CO SAYS VISIOLI REPLACED WILLIAM O’CONNOR, WHO IS RETIRING FROM CO - SEC FILING\n* MEDICINES CO - ‍WILLIAM O'CONNOR CEASED SERVING AS CFO ON MARCH 21, 2018, BUT WILL REMAIN WITH CO AS SPECIAL ADVISOR TO CEO THROUGH 2018​ Source text: ( bit.ly/2I8wBOI ) Further company coverage:\n ", "external_links": [], "published": "2018-03-28T00:34:00.000+03:00", "crawled": "2018-03-28T00:52:29.012+03:00", "highlightTitle": ""}